The market is expected to remain range-bound, with last week’s support acting as a key base. Below are some short-term ...

Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

The S&P 500 stalled just below record highs last week, with higher timeframe analysis pointing to a bullish bias and a clear ...

Brokers are excited about the potential of the Santos Ltd (ASX: STO) share price. Here’s why investors can be excited ...

Strategists are divided on valuations — specifically, on the direction of the forward price-earnings (P/E) ratio as it hovers ...

Discover why Newmont (NEM) is poised for growth with strong cash flow, a solid balance sheet, and undervalued trading—read ...

Discover top portfolio strategies blending market timing & sector insights. See how 10 proprietary models consistently beat ...

Goldman Sachs Nasdaq-100 Premium Income ETF stands out for its stability, tax benefits, and growth. Read why I recently added ...

While Nvidia and Broadcom are both benefiting from the AI boom, Wall Street sees one stock as a much better buy.

Value Line's core operations, especially print and digital investment periodicals, are in structural decline. Read why VALU ...

While some investors have grown cautious, one Wall Street analyst just doubled their price target on this fan-favorite stock.

FRDM targets democratic nations, holds Samsung, TSMC, trades at 15.04 P/E, yields 2.11%, freedom-weighted. Read why FRDM ETF ...